Europe · Wires & real time · AFP Économie

Ropeg obtient les autorisations de mise sur le marché dans les principaux marchés mondiaux, tandis que les patients européens attendent toujours de pouvoir bénéficier de ...

Published by AFP Économie · France 1 d ago

Le traitement de PharmaEssentia destiné aux cancers du sang, le ropeginterféron alfa-2b (Ropeg), a obtenu des autorisations de mise sur le marché pour la thrombocytémie…

Read the full article on AFP Économie Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.afp.com)

Also worth reading

TASS

Russian people united in sincere support for special military operation heroes — Putin

Anadolu Agency

Brent crude falls below $100 a barrel for first time in month as European gas prices drop

Reuters Europe Markets

European far right distances itself from Trump, blaming Iran war for Republicans' defeat

Reuters US Markets

Prediction markets get Democratic win right, with a few surprises

Reuters Business

NBCUniversal, MIT Investment join Indian microdrama firm's $80 million funding round

Reuters Asia Markets